Contraceptive-induced menstrual changes (CIMCs) contribute to both non-use and discontinuation of contraception. Reduced bleeding and...

Read more about the updated CYP on the FHI 360 website and USAID's website. Couple year protection (CYP) is an output indicator that was...

Post written by Margaret Gaw, Stanback Fellow with FHI 360 A new report by the British Pregnancy Advisory Service (BPAS), researchers at...

The COVID-19 pandemic has created acute disruptions to public health supply chains, revealing underlying vulnerabilities in the global...

The drospirenone progestin-only pill (POP) is an estrogen-free daily oral contraceptive that received regulatory approval in both the US...

The United States Food and Drug Administration (FDA) approved Mirena® for an additional year of duration, extending its indication for up...

Sparked by conversations from the 2019 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)...

The U.S. Food and Drug Administration has issued approval for a new type of birth control gel.

The Global Health Network has announced that the Trials Methodology Research Partnership (TMRP) has made available funds for small...

A woman’s menstrual cycle – though critical for conceiving life, can also be painful, messy, and downright uncomfortable. And, women who...

Amphora, an investigational Multipurpose Vaginal pH Regulator (MVP-RTM), shows promise for the United States Food and Drug Administration...

On December 11, 2019, Amneal Pharmaceuticals received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug...

Researchers from the Georgia Institute of Technology, University of Michigan and FHI 360, are attempting to expand the number of user...

Researchers may have found a novel delivery mechanism that will allow an extended release birth control pill to provide one month of...

In late September, the Federal Drug Administration (FDA) hosted its second annual Complex Generic Drug Product Development Workshop...

Medicines360 and Allergan announced the U.S. Food and Drug Administration (FDA) approved the extension of LILETTA® (levonorgestrel...

Imagine using one product or method to safeguard against an unwanted pregnancy or a sexually transmitted infection. Well, there’s a tech...

Novel research from David Pépin’s lab's research may serve women as both a contraceptive and a fertoprotective – protecting against the...

The Demographic and Health Surveys (DHS) Program has updated its questionnaires for DHS-8. Since 1984, the DHS Program has provided...

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has publicly released its updated five-year...

On July 11, 2019, the U.N. Human Rights Council (HRC) adopted a new resolution on “Access to medicines and vaccines in the context of the...

The ECHO trial, a randomized controlled trial, found no meaningful difference in risk of HIV acquisition across three contraceptive...

In response to observational studies that suggest a link between DMPA and risk fo HIV acquisition, FHI 360 has developed a modeling tool...

YourChoice Therapeutics is attempting to revolutionize birth control options for women & men by developing options that are hormone-free...

Ovaprene®, a non-hormonal, monthly birth control ring for women, has been identified as a first-in-category contraceptive product to...

A small percentage of women may become pregnant even with “perfect” use of contraceptives. Researchers have turned to pharmacogenetics to...

In the future, preventing pregnancy may be as easy as putting on jewelry. According to an article in the Journal of Controlled Release...

Since 2015, the CTI Exchange has served as a platform to increase global access to information and resources that supports contraceptive ...

The Demographic and Health Surveys (DHS) Program is currently soliciting feedback on its model questionnaires, optional modules, and bio...

The NICHD has issued a Request for Information (RFI) to solicit feedback on its new strategic plan. NICHD is seeking input from a variety...

Sustained hormonal release of a contraceptive hormone may be possible via the use of biodegradable levonorgestrel-releasing microneedle...

The United States Food and Drug Administration (U.S.FDA) has plans to create the Office of Drug Evaluation Science (ODES) in an effort to...

From November 12-15, more than 3,700 people gathered for the fifth International Conference on Family Planning (ICFP) in Kigali, Rwanda....

In November 2018, the Population Council, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the..

The CTI Exchange joins global partners in celebrating World Contraception Day which takes place on September 26th each year. To celebrate...

On August 10, 2018, the U.S. Food and Drug Administration made two major announcements related to contraception. First, it permitted ...

The Contraceptive Technology Innovation Exchange’s summer social media campaign aims to highlight the importance of new contraceptive...

The Center for Global Development (CGD) and Kaiser Family Foundation (KFF) held an international family planning leadership retreat from...

A recently published article reports on a phase I/II pharmacokinetic and pharmacodynamic clinical trial of two levonorgestrel (LNG)-only ...

A recently published article in Reproductive Health summarizes research on women’s responses to contraceptive-induced menstrual bleeding...

Contraceptive vaginal rings (CVRs) offer women a self-controlled, non-daily delivery system. One CVR – the FDA approved NuvaRing® – is on...

Male contraceptive targets under development focus on sperm production or sperm delivery (blockage or loss of function). One protein of...

Daré Bioscience and Orbis Biosciences have agreed to collaborate on development of two etonogestrel-based injectable contraceptives. The...

The 2018 edition of “Family Planning: A Global Handbook for Providers” is now available. The handbook provides up-to-date family planning...

DKT International and Shanghai Dahua Pharmaceutical have entered into a strategic partnership to expand the availability, accessibility...

The U.S. Food and Drug Administration has released a proposed order to reclassify & rename the single-use female condom. Reclassification...

The U.S. Food and Drug Administration (FDA) has accepted for review a contraceptive vaginal ring developed by the Population Council...

CAPRI is a curated repository of information on 27 APIs (five estrogens, 21 progestins, and one selective progesterone receptor modulator...

On the heels of our recent blog series on contraceptive method acceptability comes new research findings on end-user product preferences...

Female sterilization is the most widely used contraceptive method in the world. Meanwhile, vasectomycontinues to plateau, something it’s...